Lyell(LYEL) - 2021 Q4 - Annual Report

Table of Contents Commission file number 001-40502 _________________________________ Lyell Immunopharma, Inc. _________________________________ (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________ FORM 10-K _________________________________ (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 o TRANSITION REPORT P ...